Trials / Unknown
UnknownNCT05738655
Effectiveness of Pumpkin Seed Extract on Improving Blood Sugar Level in Subhealth Subjects
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Greenyn Biotechnology Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This randomized, double-blind, placebo-controlled, and parallel clinical study aims to investigate the effectivness of a pumpkin seed extract on blood sugar management in subhealth people.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Pumpkin seed extract (Low dose) | Pumpkin seed extract standardized with specific peptides (300 mg/day) |
| DIETARY_SUPPLEMENT | Pumpkin seed extract (High dose) | Pumpkin seed extract standardized with specific peptides (600 mg/day) |
| DIETARY_SUPPLEMENT | Placebo | Placeo (300 mg/day) |
Timeline
- Start date
- 2023-03-01
- Primary completion
- 2024-09-30
- Completion
- 2024-10-31
- First posted
- 2023-02-22
- Last updated
- 2024-02-23
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05738655. Inclusion in this directory is not an endorsement.